![Transparency Market Researchが調査・発行した産業分析レポートです。医薬品開発業務受託機関の世界市場：サービス種類別（初期フェーズ開発[発見サービス、化学、前臨床サービス]、臨床研究サービス[フェーズI、フェーズII、フェーズIII、フェーズIV]、ラボサービス[バイオ分析サービス、分析サービス、その他]、コンサルティングサービス）、治療適応症別（腫瘍学、感染症、免疫疾患、呼吸器疾患、心血管疾患、神経疾患、その他）、エンドユーザー別（医療機器会社、バイオ医薬品会社、その他） / Contract Research Organization (CRO) Services Market (Service Type: Early Phase Development [Discovery Services, Chemistry, and Preclinical Services], Clinical Research Services [Phase I, Phase II, Phase III, and Phase IV], Laboratory Services [Bioanalytical Services, Analytical Services, and Others], and Consulting Services; Therapeutic Indication: Oncology, Infectious Diseases, Immunological Disorders, Respiratory Diseases, Cardiovascular Diseases, Neurological Disorders, and Others; and End User: Medical Device Companies, Biopharmaceutical Companies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / D0JU09044資料のイメージです。](https://www.marketresearch.co.jp/images-folder2/report-contents-99.gif) | • レポートコード：D0JU09044 • 出版社/出版日：Transparency Market Research / 2020年2月13日 • レポート形態：英文、PDF、268ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、医薬品開発業務受託機関の世界市場について調査・分析し、序論、仮定・アクロニム、エグゼクティブサマリー、調査手法、市場動向、市場概要、サービス種類別（初期フェーズ開発[発見サービス、化学、前臨床サービス]、臨床研究サービス[フェーズI、フェーズII、フェーズIII、フェーズIV]、ラボサービス[バイオ分析サービス、分析サービス、その他]、コンサルティングサービス）分析、治療適応症別（腫瘍学、感染症、免疫疾患、呼吸器疾患、心血管疾患、神経疾患、その他）分析、エンドユーザー別（医療機器会社、バイオ医薬品会社、その他）分析、地域別分析、競争状況などの構成でお届けいたします。 ・序論 ・仮定・アクロニム ・エグゼクティブサマリー ・調査手法 ・市場動向 ・市場概要 ・医薬品開発業務受託機関の世界市場：サービス種類別（初期フェーズ開発[発見サービス、化学、前臨床サービス]、臨床研究サービス[フェーズI、フェーズII、フェーズIII、フェーズIV]、ラボサービス[バイオ分析サービス、分析サービス、その他]、コンサルティングサービス） ・医薬品開発業務受託機関の世界市場：治療適応症別（腫瘍学、感染症、免疫疾患、呼吸器疾患、心血管疾患、神経疾患、その他） ・医薬品開発業務受託機関の世界市場：エンドユーザー別（医療機器会社、バイオ医薬品会社、その他） ・医薬品開発業務受託機関の世界市場：地域別 ・競争状況 |
Contract Research Organization (CRO) Services Market – Scope of the Report
TMR’s report on the global contract research organization (CRO) services market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the global market during the forecast period i.e. from 2019 to 2027. The report provides the overall revenue of the global contract research organization (CRO) services market for the 2017–2027 period, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compounded annual growth rate (CAGR) for the global contract research organization (CRO) services market for the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with market leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global contract research organization (CRO) services market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global contract research organization (CRO) services market.
The report includes an elaborate executive summary, along with a snapshot of the growth pattern of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competition dynamics in the global contract research organization (CRO) services market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global contract research organization (CRO) services market. The next section of the report highlights the USPs, which include regulatory scenarios for contract research organization (CRO) services globally, business models, pricing analysis, and market developments in the global contract research organization (CRO) services market.
The report delves into the competition landscape of the global contract research organization (CRO) services market. Key players operating in the global contract research organization (CRO) services market have been identified and each one of these has been profiled for its distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global contract research organization (CRO) services market report.
Key Questions Answered in Contract Research Organization (CRO) Services Market Report
How much sales revenue would be generated by CRO services across all regions during the forecast period?
What are key trends in the global contract research organization (CRO) services market?
What are major drivers, restraints, and opportunities in the global contract research organization (CRO) services market?
Which regional market is set to expand at the most rapid CAGR during the forecast period?
Which segment would generate the maximum revenue by 2027 and which service type segment would expand at the most rapid CAGR during the forecast period?
Contract Research Organization (CRO) Services Market – Research Objectives and Research Approach
The comprehensive report on the global contract research organization (CRO) services market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and health care compliances laid down by accredited agencies in the purview of research in the global contract research organization (CRO) services market. It is followed by market introduction, market dynamics, and an overview of the global contract research organization (CRO) services market, which includes TMR’s analysis of market drivers, restraints, and trends affecting the market. Furthermore, Y-o-Y growth analysis with elaborate insights has been provided to understand the Y-o-Y growth trends of the global market. The next section of the global contract research organization (CRO) services market report highlights the USPs, which include regulatory scenarios for contract research organization (CRO) services globally, market value chain analysis, and developments in the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.
Revenue generated by key players in the contract research organization (CRO) services market has been mapped to ascertain the size of the global contract research organization (CRO) services market, in terms of value. The forecast presented here assesses the total revenue generated in the global contract research organization (CRO) services market. In order to provide an accurate forecast, we initiated by sizing up the current contract research organization (CRO) services market with the help of the parent market.
The report analyzes the global contract research organization (CRO) services market in terms of service type, therapeutic indication, and end user. Key segments under each criteria have been studied at length and the market share for each of these by the end of 2027 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global contract research organization (CRO) services market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Acronyms
3. Research Methodology
4. Executive Summary: Global Contract Research Organization (CRO) Services Market
5. Market Overview
5.1. Definition
5.2. Market Indicators
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunities
6. Market Outlook
6.1. Global Contract Research Organization (CRO) Services Market Revenue (US$ Mn) Forecast 2017–2027
6.2. Global Contract Research Organization (CRO) Services Market Outlook
6.3. Regulatory Scenario, by Region/Global
6.4. Clinical Trials Analysis
6.5. Key Mergers and Acquisitions
6.6. Heat Map Analysis
6.7. CROs – Business Model
6.8. CROs – Pricing Strategies
7. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by Service Type
7.1. Introduction
7.2. Global CRO Services Market Value Share Analysis, by Service Type
7.3. Global CRO Services Market Value Forecast, by Service Type, 2017–2027
7.3.1. Early Phase Development
7.3.1.1. Discovery Services
7.3.1.2. Chemistry
7.3.1.3. Preclinical Services
7.3.1.3.1. Toxicology
7.3.1.3.2. Pharmacokinetics
7.3.1.3.3. Others
7.3.2. Clinical Research Services
7.3.2.1. Phase I
7.3.2.2. Phase II
7.3.2.3. Phase III
7.3.2.4. Phase IV
7.3.3. Laboratory Services
7.3.3.1. Bioanalytical Services
7.3.3.2. Analytical Services
7.3.3.3. Others
7.3.4. Consulting Services
7.4. Global CRO Services Market Attractiveness, by Service Type
8. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by Therapeutic Indication
8.1. Introduction
8.2. Global CRO Services Market Value Share Analysis, by Therapeutic Indication
8.3. Global CRO Services Market Value Forecast, by Therapeutic Indication, 2017–2027
8.3.1. Oncology
8.3.2. Infectious Diseases
8.3.3. Immunological Disorders
8.3.4. Respiratory Diseases
8.3.5. Cardiovascular Diseases
8.3.6. Neurological Disorders
8.3.7. Others
8.4. Global CRO Services Market Attractiveness, by Therapeutic Indication
9. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by End-user
9.1. Introduction
9.2. Global CRO Services Market Value Share Analysis, by End-user
9.3. Global CRO Services Market Value Forecast, by End-user, 2017–2027
9.3.1. Medical Device Companies
9.3.2. Biopharmaceutical Companies
9.3.3. Others
9.4. Global CRO Services Market Attractiveness, by End-user
10. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by Region
10.1. Regional Outlook
10.2. Global Scenario
10.3. Introduction
10.4. Global Contract Research Organization (CRO) Services Market Value Forecast, by Region
10.4.1. North America
10.4.2. Europe
10.4.3. Asia Pacific
10.4.4. Latin America
10.4.5. Middle East & Africa
10.5. Global CRO Services Market Attractiveness, by Region
11. North America Contract Research Organization (CRO) Services Market Analysis and Forecast
11.1. Key Findings
11.2. North America Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027
11.2.1. Early Phase Development
11.2.1.1. Discovery Services
11.2.1.2. Chemistry
11.2.1.3. Preclinical Services
11.2.1.3.1. Toxicology
11.2.1.3.2. Pharmacokinetics
11.2.1.3.3. Others
11.2.2. Clinical Research Services
11.2.2.1. Phase I
11.2.2.2. Phase II
11.2.2.3. Phase III
11.2.2.4. Phase IV
11.2.3. Laboratory Services
11.2.3.1. Bioanalytical Services
11.2.3.2. Analytical Services
11.2.3.3. Others
11.2.4. Consulting Services
11.3. North America Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027
11.3.1. Oncology
11.3.2. Infectious Diseases
11.3.3. Immunological Disorders
11.3.4. Respiratory Diseases
11.3.5. Cardiovascular Diseases
11.3.6. Neurological Disorders
11.3.7. Others
11.4. North America Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027
11.4.1. Medical Device Companies
11.4.2. Biopharmaceutical Companies
11.4.3. Others
11.5. North America Contract Research Organization (CRO) Services Market Value Forecast, by Country, 2017–2027
11.5.1. U.S.
11.5.2. Canada
11.6. North America Contract Research Organization (CRO) Services Market Attractiveness Analysis
11.6.1. By Service Type
11.6.2. By Therapeutic Indication
11.6.3. By End-user
11.6.4. By Country
12. Europe Contract Research Organization (CRO) Services Market Analysis and Forecast
12.1. Key Findings
12.2. Europe Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027
12.2.1. Early Phase Development
12.2.1.1. Discovery Services
12.2.1.2. Chemistry
12.2.1.3. Preclinical Services
12.2.1.3.1. Toxicology
12.2.1.3.2. Pharmacokinetics
12.2.1.3.3. Others
12.2.2. Clinical Research Services
12.2.2.1. Phase I
12.2.2.2. Phase II
12.2.2.3. Phase III
12.2.2.4. Phase IV
12.2.3. Laboratory Services
12.2.3.1. Bioanalytical Services
12.2.3.2. Analytical Services
12.2.3.3. Others
12.2.4. Consulting Services
12.3. Europe Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027
12.3.1. Oncology
12.3.2. Infectious Diseases
12.3.3. Immunological Disorders
12.3.4. Respiratory Diseases
12.3.5. Cardiovascular Diseases
12.3.6. Neurological Disorders
12.3.7. Others
12.4. Europe Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027
12.4.1. Medical Device Companies
12.4.2. Biopharmaceutical Companies
12.4.3. Others
12.5. Europe Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. U.K.
12.5.2. Germany
12.5.3. France
12.5.4. Italy
12.5.5. Spain
12.5.6. Rest of Europe
12.6. Europe Contract Research Organization (CRO) Services Market Attractiveness Analysis
12.6.1. By Service Type
12.6.2. By Therapeutic Indication
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Asia Pacific Contract Research Organization (CRO) Services Market Analysis and Forecast
13.1. Key Findings
13.2. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027
13.2.1. Early Phase Development
13.2.1.1. Discovery Services
13.2.1.2. Chemistry
13.2.1.3. Preclinical Services
13.2.1.3.1. Toxicology
13.2.1.3.2. Pharmacokinetics
13.2.1.3.3. Others
13.2.2. Clinical Research Services
13.2.2.1. Phase I
13.2.2.2. Phase II
13.2.2.3. Phase III
13.2.2.4. Phase IV
13.2.3. Laboratory Services
13.2.3.1. Bioanalytical Services
13.2.3.2. Analytical Services
13.2.3.3. Others
13.2.4. Consulting Services
13.3. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027
13.3.1. Oncology
13.3.2. Infectious Diseases
13.3.3. Immunological Disorders
13.3.4. Respiratory Diseases
13.3.5. Cardiovascular Diseases
13.3.6. Neurological Disorders
13.3.7. Others
13.4. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027
13.4.1. Medical Device Companies
13.4.2. Biopharmaceutical Companies
13.4.3. Others
13.5. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. China
13.5.2. India
13.5.3. Japan
13.5.4. Australia & New Zealand
13.5.5. Rest of Asia Pacific
13.6. Asia Pacific Contract Research Organization (CRO) Services Market Attractiveness Analysis
13.6.1. By Service Type
13.6.2. By Therapeutic Indication
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Latin America Contract Research Organization (CRO) Services Market Analysis and Forecast
14.1. Key Findings
14.2. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027
14.2.1. Early Phase Development
14.2.1.1. Discovery Services
14.2.1.2. Chemistry
14.2.1.3. Preclinical Services
14.2.1.3.1. Toxicology
14.2.1.3.2. Pharmacokinetics
14.2.1.3.3. Others
14.2.2. Clinical Research Services
14.2.2.1. Phase I
14.2.2.2. Phase II
14.2.2.3. Phase III
14.2.2.4. Phase IV
14.2.3. Laboratory Services
14.2.3.1. Bioanalytical Services
14.2.3.2. Analytical Services
14.2.3.3. Others
14.2.4. Consulting Services
14.3. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027
14.3.1. Oncology
14.3.2. Infectious Diseases
14.3.3. Immunological Disorders
14.3.4. Respiratory Diseases
14.3.5. Cardiovascular Diseases
14.3.6. Neurological Disorders
14.3.7. Others
14.4. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027
14.4.1. Medical Device Companies
14.4.2. Biopharmaceutical Companies
14.4.3. Others
14.5. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. Brazil
14.5.2. Mexico
14.5.3. Rest of Latin America
14.6. Latin America Contract Research Organization (CRO) Services Market Attractiveness Analysis
14.6.1. By Service
14.6.2. By Therapeutic Indication
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Middle East & Africa Contract Research Organization (CRO) Services Market Analysis and Forecast
15.1. Key Findings
15.2. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027
15.2.1. Early Phase Development
15.2.1.1. Discovery Services
15.2.1.2. Chemistry
15.2.1.3. Preclinical Services
15.2.1.3.1. Toxicology
15.2.1.3.2. Pharmacokinetics
15.2.1.3.3. Others
15.2.2. Clinical Research Services
15.2.2.1. Phase I
15.2.2.2. Phase II
15.2.2.3. Phase III
15.2.2.4. Phase IV
15.2.3. Laboratory Services
15.2.3.1. Bioanalytical Services
15.2.3.2. Analytical Services
15.2.3.3. Others
15.2.4. Consulting Services
15.3. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027
15.3.1. Oncology
15.3.2. Infectious Diseases
15.3.3. Immunological Disorders
15.3.4. Respiratory Diseases
15.3.5. Cardiovascular Diseases
15.3.6. Neurological Disorders
15.3.7. Others
15.4. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027
15.4.1. Medical Device Companies
15.4.2. Biopharmaceutical Companies
15.4.3. Others
15.5. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027
15.5.1. GCC
15.5.2. South Africa
15.5.3. Rest of Middle East & Africa
15.6. Middle East & Africa Contract Research Organization (CRO) Services Market Attractiveness Analysis
15.6.1. By Service
15.6.2. By Therapeutic Indication
15.6.3. By End-user
15.6.4. By Country/Sub-region
16. Competition Landscape
16.1. Competition Matrix
16.2. Global CRO Services Market Share Analysis, by Company, 2018
16.3. Company Profiles
16.3.1. Laboratory Corporation of America Holdings
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Strategic Overview
16.3.1.5. SWOT Analysis
16.3.2. IQVIA Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Financial Overview
16.3.2.3. Product Portfolio
16.3.2.4. Strategic Overview
16.3.2.5. SWOT Analysis
16.3.3. Syneos Health, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Financial Overview
16.3.3.3. Product Portfolio
16.3.3.4. Strategic Overview
16.3.3.5. SWOT Analysis
16.3.4. Parexel International Corporation
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Financial Overview
16.3.4.3. Product Portfolio
16.3.4.4. Strategic Overview
16.3.4.5. SWOT Analysis
16.3.5. PRA Health Sciences, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Financial Overview
16.3.5.3. Product Portfolio
16.3.5.4. Strategic Overview
16.3.5.5. SWOT Analysis
16.3.6. PPD, Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Financial Overview
16.3.6.3. Product Portfolio
16.3.6.4. Strategic Overview
16.3.6.5. SWOT Analysis
16.3.7. Charles River Laboratories, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Financial Overview
16.3.7.3. Product Portfolio
16.3.7.4. Strategic Overview
16.3.7.5. SWOT Analysis
16.3.8. Icon plc
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Financial Overview
16.3.8.3. Product Portfolio
16.3.8.4. Strategic Overview
16.3.8.5. SWOT Analysis
16.3.9. WuXi AppTec Group
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Financial Overview
16.3.9.3. Product Portfolio
16.3.9.4. Strategic Overview
16.3.9.5. SWOT Analysis
16.3.10. Medpace
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Financial Overview
16.3.10.3. Product Portfolio
16.3.10.4. Strategic Overview
16.3.10.5. SWOT Analysis
List of TablesTable 01: CROs - Heat Map Analysis
Table 02: CROs – Business Models
Table 03: Global CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027
Table 04: Global CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027
Table 05: Global CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027
Table 06: Global CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027
Table 07: Global CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027
Table 08: Global CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027
Table 09: Global CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 10: Global CRO Services Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 11: North America CRO Services Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 12: North America CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027
Table 13: North America CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027
Table 14: North America CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027
Table 15: North America CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027
Table 16: North America CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027
Table 17: North America CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027
Table 18: North America CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 19: Europe CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 20: Europe CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027
Table 21: Europe CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027
Table 22: Europe CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027
Table 23: Europe CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027
Table 24: Europe CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027
Table 25: Europe CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027
Table 26: Europe CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 27: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 28: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027
Table 29: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027
Table 30: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027
Table 31: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027
Table 32: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027
Table 33: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027
Table 34: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 35: Latin America CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 36: Latin America CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027
Table 37: Latin America CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027
Table 38: Latin America CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027
Table 39: Latin America CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027
Table 40: Latin America CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027
Table 41: Latin America CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027
Table 42: Latin America CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 43: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 44: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027
Table 45: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027
Table 46: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027
Table 47: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027
Table 48: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027
Table 49: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027
Table 50: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027